Bronchopulmonary hyperreactivity and lung eosinophil sequestration but not their migration to the alveolar compartment are independent of interleukin-5 in allergic mice

European Cytokine Network

Volumn 13, Issue 3, 2002, Pages 340-349

  Proust, Barbara ^a   Ruffié, Claude ^a   Lefort, Jean ^a   Vargaftig, B Boris ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Bronchopulmonary hyperreactivity; Eosinophilia; IL 5; TRFK 5

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; LIPOPOLYSACCHARIDE; METHACHOLINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TRFK 5; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; IMMUNE SYSTEM; IMMUNIZATION; INFLAMMATION; LUNG ALVEOLUS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL COMPARTMENTATION; CELL MOVEMENT; EOSINOPHILS; HYPERSENSITIVITY; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MALE; MICE; MICE, INBRED BALB C; PULMONARY ALVEOLI; SPECIES SPECIFICITY;

ANIMALIA; BRONCHUS;

EID: 0036635842     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bronchial hyperreactivity
2. The eosinophil and bronchial asthma: Current understanding
3. T cells and eosinophils in the pathogenesis of asthma
4. Recombinant human interleukin 5 is a selective activator of human eosinophil function
5. Recombinant interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
6. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
7. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells
8. IL-4 directs the development of Th2-like helper effectors
9. Differential regulation of IgG1 and IgE synthesis by interleukin 4
10. Interleukin-4: A prototype immunoregulatory lymphokine
11. Predominant Th2-like bronchoalveolar lavage T-lymphocyte population in atopic asthma
12. +T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
13. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
14. T cell subsets and their soluble products regulate eosinophilia in allergic and non allergic asthma
15. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness
16. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
17. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
18. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice
19. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness
20. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
21. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
22. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
23. Development of airway hyperresponsiveness is dependent on interferon-γ and independent of eosinophil infiltration
24. Dissociation of hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma
25. Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma
26. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
27. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
28. The characterization of four antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent
29. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice
30. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay
31. Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media
32. Anti-interleukin 5 strategies as a potential treatment for asthma
33. Interleukin-5
34. Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilisation and bronchial hyperresponsiveness
35. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsivess in mice
36. Cytodynamics of the immune response in two lines of mice genetically selected for "high" and "low" antibody synthesis
37. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia
38. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody
39. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice
40. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice
41. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: Involvement of bone marrow IL-5 and IL-5 receptor α
42. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma
43. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
44. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
45. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5